Search - tctmd.com

Displaying 781 - 800 of 1038

Sort: Relevancy | Date

News Conference News AHA 2015

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Todd Neale

November 10, 2015

News Conference News AHA 2015

Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower

Yael L. Maxwell

November 08, 2015

News Daily News

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

Yael L. Maxwell

November 04, 2015

News Daily News

Despite Drawbacks and Frustration, EHRs Could Have Meaningful Benefit in Acute MI Patients

Yael L. Maxwell

October 30, 2015

News Daily News

Morphine’s Worrisome Effects on Ticagrelor Affirmed in Pharmacokinetic Study

Shelley Wood

October 29, 2015

Presentation

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Presenter: Schjerning Olsen

October 28, 2015

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

News Conference News TCT 2015

IBIS-4: Rosuvastatin Tied to Plaque Stability in STEMI

Yael L. Maxwell

October 16, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Conference News TCT 2015

Despite Setbacks, Research Into Myocardial Salvage Continues

October 12, 2015

News Conference News TCT 2015

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

October 11, 2015

News Daily News

Transradial PCI May Attenuate Bivalirudin Benefits

Todd Neale

October 05, 2015

News Daily News

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

L.A. McKeown

September 21, 2015

News Daily News

RECLOSE-3: Shifting Clopidogrel Nonresponders to Prasugrel Lowers Mortality After PCI

Yael L. Maxwell

September 18, 2015

News Industry News

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

September 10, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Industry News

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

September 09, 2015

News Industry News

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

September 08, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

Advertisement

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

Despite Drawbacks and Frustration, EHRs Could Have Meaningful Benefit in Acute MI Patients

Morphine’s Worrisome Effects on Ticagrelor Affirmed in Pharmacokinetic Study

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

IBIS-4: Rosuvastatin Tied to Plaque Stability in STEMI

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Discussion Highlights Merits, Limitations of Small Trials

Despite Setbacks, Research Into Myocardial Salvage Continues

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

Transradial PCI May Attenuate Bivalirudin Benefits

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

RECLOSE-3: Shifting Clopidogrel Nonresponders to Prasugrel Lowers Mortality After PCI

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content